Skip to Main Content

Author Details

Manoel Barral-Netto
Instituto Goncalo Moniz
1948
312
54
PMIDPaper TitleJournal TitlePublished Year
36630477Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.PLoS Med2023
37517045Epidemiology of chronic kidney disease in older indigenous peoples of Brazil: findings from a cross-sectional survey.Aging Clin Exp Res2023
37601355High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil.Front Microbiol2023
37055776Previous BCG vaccination is associated with less severe clinical progression of COVID-19.BMC Med2023
37453442Effectiveness of monovalent and bivalent COVID-19 vaccines.Lancet Infect Dis2023
37386490Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study.BMC Public Health2023
37376536Analyses of Early ZIKV Genomes Are Consistent with Viral Spread from Northeast Brazil to the Americas.Viruses2023
37166260Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group.J Glob Health2023
36681085The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era.Lancet Infect Dis2023
36732348Urbanization and cardiovascular health among Indigenous groups in Brazil.Commun Med (Lond)2023
34957437Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study.Lancet Reg Health Am2022
35846888Tucuxi-BLAST: Enabling fast and accurate record linkage of large-scale health-related administrative databases through a DNA-encoded approach.PeerJ2022
35379250CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.BMC Med2022
35366959Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.Lancet Infect Dis2022
35851597Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil.Nat Commun2022
35588753Vaccination plus previous infection: protection during the omicron wave in Brazil.Lancet Infect Dis2022
36593577Effectiveness of covid-19 vaccines in adolescents and children.BMJ2022
36315558Metabolic disorders and post-acute hospitalization in black/mixed-race patients with long COVID in Brazil: A cross-sectional analysis.PLoS One2022
36146794Heart Disease and Arboviruses: A Systematic Review and Meta-Analysis.Viruses2022
36135358SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study.Elife2022
35963844Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period.Nat Commun2022
36356609Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil.Lancet Infect Dis2022
35952702Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.Lancet Infect Dis2022
34942103Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.Lancet2022
34904289Can urbanisation influence alcohol consumption by Indigenous groups? A brief analysis of Brazilian data.Drug Alcohol Rev2022
35140406Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.Nat Med2022
32894278A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.Clin Infect Dis2021
33823183Selective Suppression of Cellular Immunity and Increased Cytotoxicity in Skin Lesions of Disseminated Leishmaniasis Uncovered by Transcriptome-Wide Analysis.J Invest Dermatol2021
33630746Bridging Learning in Medicine and Citizenship During the COVID-19 Pandemic: A Telehealth-Based Case Study.JMIR Public Health Surveill2021
34727121Dissecting disease tolerance in Plasmodium vivax malaria using the systemic degree of inflammatory perturbation.PLoS Negl Trop Dis2021
34417262LTB<sub>4</sub>-Driven Inflammation and Increased Expression of <i>ALOX5</i>/<i>ACE2</i> During Severe COVID-19 in Individuals With Diabetes.Diabetes2021
34181663Anti-chikungunya virus seroprevalence in Indigenous groups in the São Francisco Valley, Brazil.PLoS Negl Trop Dis2021
33253864Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial.Int J Infect Dis2021
33293339Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.Science2021
31553527Evolution of cytokines/chemokines in cases with community-acquired pneumonia and distinct etiologies.Pediatr Pulmonol2020
33263602Investigating associations between intestinal alterations and parasite load according to Bifidobacterium spp. and Lactobacillus spp. abundance in the gut microbiota of hamsters infected by Leishmania infantum.Mem Inst Oswaldo Cruz2020
32693402A clinical scoring system to predict long-term arthralgia in Chikungunya disease: A cohort study.PLoS Negl Trop Dis2020
32941627The re-emergence of Zika in Brazil in 2020: a case of Guillain Barré Syndrome during the low season for arboviral infections.J Travel Med2020
32653040The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19.Respir Res2020
32851099Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis.J Immunol Res2020
32784775Chronic Hepatitis B Infection Is Associated with Increased Molecular Degree of Inflammatory Perturbation in Peripheral Blood.Viruses2020
32756829Reorganization of primary health care for universal surveillance and containment of COVID-19.Epidemiol Serv Saude2020
32186714Oral lesions are frequent in patients with Chikungunya infection.J Travel Med2020
32520293Personal data usage and privacy considerations in the COVID-19 global pandemic.Cien Saude Colet2020
30528394Elevated IL-17 levels and echocardiographic signs of preserved myocardial function in benznidazole-treated individuals with chronic Chagas' disease.Int J Infect Dis2019
34095542The Centre for Data and Knowledge Integration for Health (CIDACS): Linking Health and Social Data in Brazil.Int J Popul Data Sci2019
31832561Improving the serodiagnosis of canine <i>Leishmania infantum</i> infection in geographical areas of Brazil with different disease prevalence.Parasite Epidemiol Control2019
31891152Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in <i>L. infantum</i>-infected dogs.Vaccine X2019
31850398An open toolkit for tracking open science partnership implementation and impact.Gates Open Res2019
31474994The Transcriptional and Protein Profile From Human Infected Neuroprogenitor Cells Is Strongly Correlated to Zika Virus Microcephaly Cytokines Phenotype Evidencing a Persistent Inflammation in the CNS.Front Immunol2019
  • 1 - 50 of 312

Recommended Authors

University of California los angeles
Career Start Year 2010
Number of shared co-authors 0
Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences
Career Start Year 2006
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases/National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
The Barcelona Institute for Science and Technology
Career Start Year 2003
Number of shared co-authors 1
University Hospital Fundacion Alcorcon
Career Start Year 2001
Number of shared co-authors 0
Begin Military Teaching Hospital
Career Start Year 1999
Number of shared co-authors 0
Centro Sandoval and Hospital Universitario Clinico de San Carlos
Career Start Year 1999
Number of shared co-authors 0
National Institutes of Health Intramural Research Program
Career Start Year 1995
Number of shared co-authors 0
Lausanne University Hospital
Career Start Year 1994
Number of shared co-authors 0
Hospital Chemnitz
Career Start Year 1991
Number of shared co-authors 0
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Morehouse School of Medicine
Career Start Year 1988
Number of shared co-authors 0
University of Washington
Career Start Year 1986
Number of shared co-authors 0
Hospital Clinico Universitario de Valladolid
Career Start Year 1985
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 1984
Number of shared co-authors 1
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1982
Number of shared co-authors 0
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Career Start Year 1982
Number of shared co-authors 1
School of Public Health, Yale University
Career Start Year 1982
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1981
Number of shared co-authors 0
The University of Notre Dame Australia
Career Start Year 1979
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1978
Number of shared co-authors 0
Italian Ministry of Health
Career Start Year 1977
Number of shared co-authors 0
University of California
Career Start Year 1976
Number of shared co-authors 0
Lydia Becker Institute for Immunology & Infection, University of Manchester
Career Start Year 1974
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 1
Allergy and Clinical Immunology, University of California at Davis
Career Start Year 1967
Number of shared co-authors 0
New York State Psychiatric Institute
Career Start Year 1964
Number of shared co-authors 1
University of Florida Health
Career Start Year 1961
Number of shared co-authors 0

Collaborators

Co-authored papers 3
Vitalant Research Institute
Co-authored papers 2
Federal University of Mato Grosso do Sul
Co-authored papers 2
Heart Institute (InCor), Faculdade de Medicina, Universidade de Sao Paulo
Co-authored papers 2
Global Health Pharma Unit
Co-authored papers 1
Co-authored papers 1
Glaxo Research and Development Ltd.
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
McGill University
Co-authored papers 1
Arizona State University
Co-authored papers 1
Institute of Education, University of London
Co-authored papers 1
Warwick Medical School, University of Warwick
Co-authored papers 1
University of Wolverhampton
Co-authored papers 1
Rega Institute, Laboratory of Clinical and Evolutionary Virology
Co-authored papers 1
Stanford University
Co-authored papers 1
Ipswich Hospital
Co-authored papers 1
Instituto Oswaldo Cruz
Co-authored papers 1
Queensland University of Technology
Co-authored papers 1
McGill University
Co-authored papers 1
Center for Open Science
Co-authored papers 1
Universidade do Estado do Amazonas
Co-authored papers 1
Children's Hospital Oakland Research Institute
Co-authored papers 1
McGill University
Co-authored papers 1
Escola Nacional de Saude Publica Sergio Arouca
Co-authored papers 1
African Academy of Sciences
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
US Department of Agriculture Economic Research Service
Co-authored papers 1
University of Wales
Co-authored papers 1
Montreal Neurological Institute-Hospital
Co-authored papers 1